SE454946B - Vattendispersion av salbutamol och ett cellulosaderivat - Google Patents

Vattendispersion av salbutamol och ett cellulosaderivat

Info

Publication number
SE454946B
SE454946B SE8303012A SE8303012A SE454946B SE 454946 B SE454946 B SE 454946B SE 8303012 A SE8303012 A SE 8303012A SE 8303012 A SE8303012 A SE 8303012A SE 454946 B SE454946 B SE 454946B
Authority
SE
Sweden
Prior art keywords
composition according
cellulose derivative
salbutamol
per
aqueous dispersion
Prior art date
Application number
SE8303012A
Other languages
English (en)
Swedish (sv)
Other versions
SE8303012D0 (sv
SE8303012L (sv
Inventor
J M Padfield
C V Groom
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8303012D0 publication Critical patent/SE8303012D0/xx
Publication of SE8303012L publication Critical patent/SE8303012L/
Publication of SE454946B publication Critical patent/SE454946B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8303012A 1982-05-27 1983-05-27 Vattendispersion av salbutamol och ett cellulosaderivat SE454946B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8215502 1982-05-27

Publications (3)

Publication Number Publication Date
SE8303012D0 SE8303012D0 (sv) 1983-05-27
SE8303012L SE8303012L (sv) 1983-11-28
SE454946B true SE454946B (sv) 1988-06-13

Family

ID=10530673

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303012A SE454946B (sv) 1982-05-27 1983-05-27 Vattendispersion av salbutamol och ett cellulosaderivat

Country Status (25)

Country Link
JP (1) JPH0629181B2 (es)
AT (1) AT390191B (es)
AU (1) AU567675B2 (es)
BE (1) BE896870A (es)
CA (1) CA1203176A (es)
CH (1) CH656308A5 (es)
DE (1) DE3319356C2 (es)
DK (1) DK167558B1 (es)
ES (1) ES8502336A1 (es)
FI (1) FI81257C (es)
FR (1) FR2527442B1 (es)
GR (1) GR82681B (es)
IE (1) IE55139B1 (es)
IL (1) IL68805A0 (es)
IT (1) IT1174759B (es)
LU (1) LU84828A1 (es)
MY (1) MY8700275A (es)
NL (1) NL192663C (es)
NO (1) NO163166C (es)
NZ (1) NZ204385A (es)
PH (1) PH19601A (es)
PT (1) PT76773B (es)
SE (1) SE454946B (es)
ZA (1) ZA833854B (es)
ZW (1) ZW11883A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624213A (en) * 1963-10-30 1971-11-30 Merck & Co Inc Method of sterilizing aqueous pharmaceutical solutions employing propylene oxide and entrained air
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1453034A (en) * 1972-12-15 1976-10-20 Boehringer Sohn Ingelheim Pharmaceutical composition for treating spasticity
JPS5831210B2 (ja) * 1973-04-09 1983-07-05 武田薬品工業株式会社 アンテイナスイセイケンダクエキノセイゾウホウ
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung

Also Published As

Publication number Publication date
PT76773B (en) 1986-03-27
AT390191B (de) 1990-03-26
IE831267L (en) 1983-11-27
ES522752A0 (es) 1985-01-01
NL8301900A (nl) 1983-12-16
IE55139B1 (en) 1990-06-06
GR82681B (es) 1985-02-07
DE3319356A1 (de) 1983-12-01
CH656308A5 (fr) 1986-06-30
FR2527442B1 (fr) 1987-07-17
NO163166C (no) 1990-05-02
ZW11883A1 (en) 1984-12-19
CA1203176A (en) 1986-04-15
AU1503983A (en) 1983-12-01
IT8348384A0 (it) 1983-05-27
DK167558B1 (da) 1993-11-22
IL68805A0 (en) 1983-09-30
PT76773A (en) 1983-06-01
ZA833854B (en) 1985-01-30
NL192663B (es) 1997-08-01
DE3319356C2 (de) 1996-07-04
ATA195283A (de) 1989-09-15
JPS591411A (ja) 1984-01-06
DK241783D0 (da) 1983-05-27
SE8303012D0 (sv) 1983-05-27
JPH0629181B2 (ja) 1994-04-20
FR2527442A1 (fr) 1983-12-02
NO163166B (no) 1990-01-08
MY8700275A (en) 1987-12-31
BE896870A (fr) 1983-11-28
DK241783A (da) 1983-11-28
AU567675B2 (en) 1987-12-03
IT1174759B (it) 1987-07-01
NZ204385A (en) 1986-07-11
FI81257C (fi) 1990-10-10
NO831875L (no) 1983-11-28
FI81257B (fi) 1990-06-29
FI831893A0 (fi) 1983-05-27
PH19601A (en) 1986-05-27
SE8303012L (sv) 1983-11-28
FI831893L (fi) 1983-11-28
NL192663C (nl) 1997-12-02
LU84828A1 (fr) 1985-03-21
ES8502336A1 (es) 1985-01-01

Similar Documents

Publication Publication Date Title
JP4940527B2 (ja) 持続性育毛組成物
JP2590156B2 (ja) 経口投与用医薬組成物
FR2712807B1 (fr) Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
JP2979446B2 (ja) 口腔用組成物
JP2002179541A (ja) カチオン性殺菌剤を含む口腔用組成物
US4594359A (en) Pharmaceutical compositions
RU2363462C2 (ru) Фармацевтическая композиция, содержащая 5-метил-2-(2′-хлор-6′-фторанилин)фенилуксусную кислоту
NZ552182A (en) Pharmaceutical composition of piperazine derivatives
SE454946B (sv) Vattendispersion av salbutamol och ett cellulosaderivat
JPH08127518A (ja) 毛髪用組成物
JP2006022091A (ja) 育毛用組成物
JP2008056703A (ja) 育毛用組成物
GB2120942A (en) Salbutamol compositions
JP3136421B2 (ja) セチルピリジニウムの安定剤
HUT63060A (en) Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists
JP2007191473A (ja) 新規な育毛用組成物
JP2001508057A (ja) 創傷および皮膚を治療するためのアミノチアゾールの使用
JP2893807B2 (ja) アズレン誘導体含有液剤
JP3364453B2 (ja) センノシド含有水性液剤
JPH11116485A (ja) スクラルファート懸濁液製剤
JP2019011271A (ja) 口腔用組成物
JPH10259132A (ja) 点鼻用水性懸濁液
JP2024091129A (ja) ビタミン誘導体含有組成物
JP2004189731A (ja) 点鼻剤
JP2020015704A (ja) 口腔用組成物

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8303012-2

Format of ref document f/p: F

NUG Patent has lapsed